TIOF PLUS

TIOF® PLUS combines Timolol 0.5% and Dorzolamide 2% to effectively reduce elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension. Its dual-action formula provides enhanced pressure control in a convenient ophthalmic solution.

Key Features

✔ Timolol 0.5% + Dorzolamide 2%
✔ Dual mechanism for IOP reduction
✔ Effective glaucoma management
✔ Sterile ophthalmic solution
✔ Convenient combination therapy
✔ 6 mL presentation

Supplier

Categoría:

Descripción

TIOF® PLUS is a combination ophthalmic solution containing Timolol Maleate 0.5% and Dorzolamide Hydrochloride 2% , indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension when monotherapy is insufficient.

The dual mechanism of action helps provide effective control of intraocular pressure by reducing aqueous humor production through complementary pathways.

Active Ingredients

  • Timolol Maleate 0.5% (5 mg/mL)
  • Dorzolamide Hydrochloride 2% (20 mg/mL)

Therapeutic Category

  • Antiglaucoma Agent
  • Beta-Adrenergic Blocker
  • Carbonic Anhydrase Inhibitor

Indications

TIOF® PLUS is indicated for:

  • Open-angle glaucoma
  • Ocular hypertension
  • Elevated intraocular pressure not adequately controlled with a single agent

Benefits

  • Dual-action glaucoma therapy
  • Effectively lowers intraocular pressure
  • Helps reduce the risk of optic nerve damage
  • Convenient combination treatment
  • May reduce the need for multiple eye medications

Valoraciones

No hay valoraciones aún.

Sé el primero en valorar “TIOF PLUS”

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *